Skip to main content
. 2021 Sep 20;8:747098. doi: 10.3389/fmed.2021.747098

Table 2.

Time to event analysis.

Before PSM After PSM
Non-IC/BPS IC/BPS Control IC/BPS
n = 21 900 n = 1,095 n = 4,224 n = 1,056
Follow up person months 1,654,806 79,147 312,164 76,839
Event of ADs 1,373 105 287 102
Incidence rate* (95% CI) 8.30 (7.87–8.75) 13.27 (10.96–16.06) 9.19 (8.19–10.32) 13.27 (10.93–16.12)
Model 1: Crude hazard ratio (95% CI) Reference 1.595 (1.308–1.945) Reference 1.442 (1.151–1.808)
*

per 10,000 person-months.

IC/BPS, interstitial cystitis/bladder pain syndrome; ADs, autoimmune diseases; PSM, propensity score matching; CI, confidence interval.